Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex

Medicine & Life Sciences

• Cystamine 100%
• Haloperidol 67%
• Brain-Derived Neurotrophic Factor 65%
• Frontal Lobe 58%
• Nerve Growth Factors 19%
• Schizophrenia 15%
• Mitogen-Activated Protein Kinase Kinases 13%
• Neuroprotection 12%
• Phosphatidylinositol 3-Kinase 12%
• Rodentia 10%
• staurosporine aglycone 9%
• Cysteamine 8%
• trkB Receptor 8%
• Neurons 7%
• 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 7%
• Apoptosis Regulatory Proteins 7%
• 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one 7%
• Mitogen-Activated Protein Kinase 3 7%
• Mitogen-Activated Protein Kinase 1 6%
• Neuropathology 6%
• Proteins 6%
• Neutralizing Antibodies 6%
• Tyrosine 5%
• Antipsychotic Agents 5%
• Cell Survival 4%
• Antioxidants 4%
• Phosphorylation 4%
• Apoptosis 3%
• Brain 3%
• In Vitro Techniques 2%

Chemical Compounds

• Cystamine 87%
• Protein 22%
• Antiapoptotic 21%
• Haloperidol 21%
• Neuroprotective 19%
• LY294002 14%
• Phosphatidylinositol 3 Kinase Inhibitor 13%
• EC 2.7.12.2 (Mitogen-Activated Protein Kinase Kinase) Inhibitor 12%
• Neurotrophic 12%
• Neuroleptic Agent 10%
• Reduction 10%
• Cysteamine 9%
• Phosphatidylinositol 9%
• Cell Viability 7%
• Marker 6%
• Antioxidant Agent 5%
• Molecule 2%